C I Traverso1, J I Arcelus, J A Caprini. Show Affiliations » 1. Department of Surgery and Related Specialties, University of Granada Hospital, Spain.
Abstract
Entities: Chemical
Mesh: See more » AdultAgedAnimalsAnticoagulants/administration & dosageAnticoagulants/pharmacologyBlood Coagulation/drug effectsClinical Trials as TopicDihydroergotamine/administration & dosageDihydroergotamine/pharmacologyDrug CombinationsHemorrhage/chemically inducedHemorrhage/prevention & controlHeparin, Low-Molecular-Weight/administration & dosageHeparin, Low-Molecular-Weight/pharmacologyHumansMiddle AgedMonitoring, Physiologic/methodsPostoperative Complications/bloodPostoperative Complications/prevention & controlProthrombin TimeRabbitsReference StandardsThrombelastographyThromboembolism/bloodThromboembolism/drug therapyThromboembolism/etiologyThromboembolism/prevention & controlWarfarin/administration & dosageWarfarin/pharmacology
Substances: See more » AnticoagulantsDrug CombinationsHeparin, Low-Molecular-Weightheparin-dihydergotDihydroergotamineWarfarin
Year: 1995 PMID: 8747690 DOI: 10.1055/s-0032-1313623
Source DB: PubMed Journal: Semin Thromb Hemost ISSN: 0094-6176 Impact factor: 4.180